Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition)

Journal of the National Cancer Center - Tập 3 - Trang 256-265 - 2023
Jianchun Duan1,2, Wenfeng Fang3, Hairong Xu4, Jinliang Wang5, Yuan Chen6, Yi Ding4, Xiaorong Dong7, Yun Fan8, Beili Gao9, Jie Hu10, Yan Huang3, Cheng Huang11, Dingzhi Huang12, Wenhua Liang13, Lizhu Lin14, Hui Liu15, Zhiyong Ma16, Meiqi Shi17, Yong Song18, Chuanhao Tang19
1CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
2Department of Respiratory Medicine, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China
3Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
4Department of Orthopaedic Oncology Surgery, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China
5Department of Oncology and Institute of Translational Medicine, Medical Innovation Research Center and the Fifth Medical Center, Chinese PLA General Hospital, Beijing, China
6Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
7Cancer Center, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
8Department of Thoracic Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China
9Department of Thoracic Oncology, Zhejiang Cancer Hospital, Hangzhou, China
10Department of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China
11Department of Medical Oncology, Fujian Cancer Hospital, Fuzhou, China
12Department of Thoracic Medical Oncology, Lung Cancer Diagnosis and Treatment Centre, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Centre for Cancer, Tianjin, China
13Department of Thoracic Surgery/Oncology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Disease & Health, Guangzhou, China
14Department of Medical Oncology, The First Clinical Medical College, the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
15Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China
16Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
17Department of Medical Oncology, Jiangsu Cancer Hospital, Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China
18Department of Respiratory and Critical Care Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China
19Department of Oncology, Peking University International Hospital, Beijing, China

Tài liệu tham khảo

Siegel, 2017, Cancer statistics, 2017, CA Cancer J Clin, 67, 7, 10.3322/caac.21387 Ferlay, 2019, Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods, Int J Cancer, 144, 1941, 10.1002/ijc.31937 Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 68, 394, 10.3322/caac.21492 Zheng, 2022, Cancer incidence and mortality in China, 2016, J Natl Cancer Cent, 2, 1, 10.1016/j.jncc.2022.02.002 Tsuya, 2007, Skeletal metastases in non-small cell lung cancer: a retrospective study, Lung Cancer, 57, 229, 10.1016/j.lungcan.2007.03.013 Wang, 2019, The homogeneous and heterogeneous risk factors for occurrence and prognosis in lung cancer patients with bone metastasis, J Bone Oncol, 17, 10.1016/j.jbo.2019.100251 Clézardin, 2021, Bone metastasis: mechanisms, therapies, and biomarkers, Physiol Rev, 101, 797, 10.1152/physrev.00012.2019 D’Antonio, 2014, Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies, Ther Adv Med Oncol, 6, 101, 10.1177/1758834014521110 Zhang, 2021, Analysis of clinical characteristics of lung cancer combined with multiple primary malignancies in other organs, Zhongguo Fei Ai Za Zhi, 24, 7 Hirsch, 2017, Lung cancer: current therapies and new targeted treatments, Lancet, 389, 299, 10.1016/S0140-6736(16)30958-8 Cetin, 2014, Bone metastasis, skeletal-related events, and mortality in lung cancer patients: a Danish population-based cohort study, Lung Cancer, 86, 247, 10.1016/j.lungcan.2014.08.022 Qin, 2021, Bone metastases, skeletal-related events, and survival in patients with metastatic non–small cell lung cancer treated with immune checkpoint inhibitors, J Natl Compr Canc Netw, 19, 915, 10.6004/jnccn.2020.7668 Zhang, 2017, Clinical characteristics and prognostic factors in bone metastases from lung cancer, Med Sci Monit, 23, 4087, 10.12659/MSM.902971 Yu, 2012 Quint, 1996, Distribution of distant metastases from newly diagnosed non-small cell lung cancer, The Ann Thorac Surg, 62, 246, 10.1016/0003-4975(96)00220-2 Xu, 2019, The correlation between different pathological types of lung cancer and clinical features of bone metastasis, Chinese J Orthop, 39, 329 Liu, 2021, Epidemiological characteristics of lung cancer patients with spinal metastases, Chinese J Spinal Cord, 31, 103 Coleman, 1997, Skeletal complications of malignancy, Cancer, 80, 1588, 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G Sun, 2007, 7, 135 Zheng, 2019, Incidence, prognostic factors, and a nomogram of lung cancer with bone metastasis at initial diagnosis: a population-based study, Transl Lung Cancer Res, 8, 367, 10.21037/tlcr.2019.08.16 Peters, 2019, The RANK–RANKL axis: an opportunity for drug repurposing in cancer?, Clin Transl Oncol, 21, 977, 10.1007/s12094-018-02023-5 Roodman, 2004, Mechanisms of bone metastasis, N Engl J Med, 350, 1655, 10.1056/NEJMra030831 Ren, 2020, Clinical features and prognosis of 169 newly diagnosed lung cancer patients with bone metastasis, J Pract Oncol, 35, 322 De Castro, 2015, Therapeutic potential of denosumab in patients with lung cancer: beyond prevention of skeletal complications, Clin Lung Cancer, 16, 431, 10.1016/j.cllc.2015.06.004 Santini, 2015, Natural history of non-small-cell lung cancer with bone metastases, Sci Rep, 5, 1, 10.1038/srep18670 Jiang, 2009, Expert consensus statement on clinical diagnosis and treatment of breast cancer bone metastasis and bone related diseases (2008), Zhonghua Zhong Liu Za Zhi, 31, 156 Rybak, 2001, Radiological imaging for the diagnosis of bone metastases, Q J Nucl Med, 45, 53 Yu, 2020, Application of WB-DWI and ECT bone imaging in bone metastasis of lung adenocarcinoma whole-body bone imaging, Chi J CT and MRI, 18, 39 Stecco, 2018, Whole-body MRI with diffusion-weighted imaging in bone metastases: a narrative review, Diagnostics, 8, 45, 10.3390/diagnostics8030045 Riola-Parada, 2016, Simultaneous PET/MRI vs. PET/CT in oncology. A systematic review, Rev Esp Med Nucl Imagen Mol, 35, 306 Samarin, 2015, 18F-FDG-PET/MR increases diagnostic confidence in detection of bone metastases compared with 18F-FDG-PET/CT, Nucl Med Commun, 36, 1165, 10.1097/MNM.0000000000000387 Wang, 2020, Value analysis of 99mTc-MDP SPECT/CT whole-body bone imaging and local fusion tomography in the diagnosis of bone metastasis of lung cancer, Imag Res Med App, 4, 43 Gao, 2020, Comparison of 18F-FDG PET/CT and 99mTc-MDP whole-body bone imaging in the diagnosis of lung cancer bone metastasis. Article in Chinese, Imag Res Med App, 4, 197 Planchard, 2018, Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol, 29, iv192, 10.1093/annonc/mdy275 Li, 2003, Zoledronic acid: a new parenteral bisphosphonate, Clini Ther, 25, 2669, 10.1016/S0149-2918(03)80327-2 Cui, 2020, Clinical analysis of bone metastasis from lung cancer early warning model, Chin Clin Pulm Med, 25, 1004 Mai, 2020, Diagnosis of bone metastasis of lung cancer by using SPECT, CT and bone metabolism markers combined model, Chin J Med Imag, 28, 508 Zhao, 2019, The value of diagnosis and effect evaluation of BALP, CA125 and NSE in lung cancer patients with bone metastasis. Article in Chinese, J Chin Oncol, 25, 1016 Mountzios, 2011, Prognostic significance of bone markers in patients with lung cancer metastatic to the skeleton: a review of published data, Clin Lung Cancer, 12, 341, 10.1016/j.cllc.2011.03.032 Coleman, 2010, Metastasis and bone loss: advancing treatment and prevention, Cancer Treat Rev, 36, 615, 10.1016/j.ctrv.2010.04.003 Ettinger, 2021, NCCN guidelines insights: non-small cell lung cancer, version 2.2021, J Natl Compr Canc Netw, 19, 254, 10.6004/jnccn.2021.0013 Planchard, 2018, Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol, 29, iv192, 10.1093/annonc/mdy275 Huang, 2020, Key points of the update of the 2020 CSCO guidelines for the diagnosis and treatment of non-small cell lung cancer, Clin Inter Med, 37, 603 Brahmer, 2015, Nivolumab versus Docetaxel in advanced squamous-cell non-small-cell lung cancer, N Engl J Med, 373, 123, 10.1056/NEJMoa1504627 Ahern, 2019, Pharmacodynamics of pre-operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multicentre, open-label, phase 1B/2, translational trial (POPCORN), Trials, 20, 753, 10.1186/s13063-019-3951-x Henry, 2011, Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma, J Clin Oncol, 29, 1125, 10.1200/JCO.2010.31.3304 Scagliotti, 2012, Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study, J Thorac Oncol, 7, 1823, 10.1097/JTO.0b013e31826aec2b Lopez-Olivo, 2012, Bisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysis, Support Care Cancer, 20, 2985, 10.1007/s00520-012-1563-z Nakahara, 2019, Multicenter study of zoledronic acid administration in non-small-cell lung cancer patients with bone metastasis: thoracic Oncology Research Group (TORG) 1017, Mol Clin Oncol, 11, 349 Sun, 2014, Expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2014 version), Zhongguo Fei Ai Za Zhi, 17, 57 Sabino, 2002, Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2, Cancer Res, 62, 7343 Fallon, 2018, Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines, Ann Oncol, 29, iv166, 10.1093/annonc/mdy152 Henry, 2014, Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors, Support Care Cancer, 22, 679, 10.1007/s00520-013-2022-1 Wang, 2021, The clinical effect of transcutaneous electrical nerve stimulation combined with low-dose oxycodone and acetaminophen on bone metastasis pain of non-small cell lung cancer, Chin J Front Med Sci, 13, 60 Cao, 2020, Application value of local radiofrequency hyperthermia combined with 89Sr elbow vein injection in patients with lung cancer bone metastasis, Henan Med Res, 29, 5817 Aielli, 2019, Bone metastasis pain, from the bench to the bedside, Int J Mol Sci, 20, 280, 10.3390/ijms20020280 Lutz, 2011, Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline, Int J Radiat Oncol Biol Phys, 79, 965, 10.1016/j.ijrobp.2010.11.026 Jabbari, 2016, Stereotactic body radiotherapy for spinal metastases: practice guidelines, outcomes, and risks, Cancer, 22, 280, 10.1097/PPO.0000000000000205 Wang, 2012, Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial, Lancet Oncol, 13, 395, 10.1016/S1470-2045(11)70384-9 Nguyen, 2011, Palliative response and functional interference outcomes using the Brief Pain Inventory for spinal bony metastases treated with conventional radiotherapy, Clin Oncol, 23, 485, 10.1016/j.clon.2011.01.507 Qian, 2016, Effect of pedicle fixation combined with 125I seed implantation for metastatic thoracolumbar tumors, Pain Res, 9, 271 Liu, 2012, Oc-75 CT-Guided interstitial Iodine-125 seed implantation in the treatment of spinal and paraspinal malignancies, Radio Oncol, 103, S30, 10.1016/S0167-8140(12)72042-X Xiang, 2016, 125I brachytherapy in the palliation of painful bone metastases from lung cancer after failure or rejection of conventional treatments, Oncotarget, 7, 18384, 10.18632/oncotarget.7584 Yang, 2020, Clinical application of radiofrequency ablation combined with 125I seed implantation in treating bone metastasis of non-small cell lung cancer, J Inter Radio, 29, 783 Zhang, 2019, Review of surgical treatment of extra-pulmonary oligometastic non-small cell lung cancer, J Clin Surg, 27, 1002 Tubiana-Hulin, 1991, Incidence, prevalence and distribution of bone metastases, Bone, 12, S9, 10.1016/8756-3282(91)90059-R Wu, 2021, Primary tumor surgery improves survival of cancer patients with synchronous solitary bone metastasis: a large population-based study, Ann Transl Med, 9, 31, 10.21037/atm-20-4764 Wen, 2020, Surgical management of lung cancer metastasis in the femur, Chin Meta Cancer, 6 Lavignac, 2020, Surgical treatment of peri-acetabular metastatic disease: retrospective, multicentre study of 91 THA cases, Orthop Traumatol Surg Res, 106, 1025, 10.1016/j.otsr.2020.03.032 Feng, 2020, Efficacy and safety of multi-segment percutaneous vertebroplasty in the treatment of osteolytic vertebral metastases, J Clin Experi Med, 19, 76 Zhao, 2020, Observation of clinical effect of using tailored Kirschner-wire cement prosthesis to treat proximal humerus malignant tumor, Ortho Bio Materials Clin Study, 17, 16 Bond, 1973, Internal fixation of secondary deposits in long bones, Br Med J, 1, 488, 10.1136/bmj.1.5851.488-c Ye, 2018, Expert consensus workshop report: guidelines for thermal ablation of primary and metastatic lung tumors (2018 edition), J Cancer Res Ther, 14, 730, 10.4103/jcrt.JCRT_221_18 Pusceddu, 2013, Treatment of bone metastases with microwave thermal ablation, J Vasc Interv Radiol, 24, 229, 10.1016/j.jvir.2012.10.009 Clarençon, 2013, Value of percutaneous radiofrequency ablation with or without percutaneous vertebroplasty for pain relief and functional recovery in painful bone metastases, Skel Radio, 42, 25, 10.1007/s00256-011-1294-0 Meng, 2020, Clinical efficacy of zoledronic acid combined with radiofrequency surgery in treatment of bone metastatic cancer pain in elderly lung cancer patients, Med J West China, 32, 414 Harding, 2018, Evaluation of quality of life outcomes following palliative treatment of bone metastases with magnetic resonance-guided high intensity focused ultrasound: an international multicentre study, Clin Oncol, 30, 233, 10.1016/j.clon.2017.12.023 Callstrom, 2013, Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trial, Cancer, 119, 1033, 10.1002/cncr.27793 Gao, 2014, Clinical application of C-arm CT in percutaneous kyphoplasty due to vertebral metastases, J Interv Radio, 23, 167 Roedel, 2015, Has the percutaneous vertebroplasty a role to prevent progression or local recurrence in spinal metastases of breast cancer?, J Neuroradiol, 42, 222, 10.1016/j.neurad.2014.02.004 Bao, 2019, Clinical observation of percutaneous vertebroplasty for advanced cervical metastasis of lung cancer, Int J Surg, 46, 181 Gangi, 2003, Percutaneous vertebroplasty: indications, technique, and results, Radiographics, 23, e10, 10.1148/rg.e10